Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in South Korea / NCT04259398
Active, not recruiting Not applicable

Anesthesia and Cancer Study: Colon Cancer

NCT04259398 · tracked via the Priya Life Science South Korea tracker
Sponsor
Seoul National University Hospital
Phase
Not applicable
Started
2020-02-18
Last updated
2023-11-22

Condition(s) studied

Cancer of ColonAnesthesia

Investigational drug(s) / intervention(s)

Propofol →Sevoflurane →

Propofol: propofol 1-2 mg/kg bolus injection for induction of anesthesia propofol continuous infusion for maintenance of anesthesia

Sevoflurane: sevoflurane is administered for induction and maintenance of anesthesia

Study summary

This study investigates the influence of type of anesthesia on survival and recurrence rate in patients receiving colon cancer surgery. The participants will be allocated to either the TIVA group and the inhalation group.

Eligibility

Sex
ALL
Min age
19 Years
Max age
80 Years
Healthy volunteers
No
Inclusion Criteria: * adults undergoing surgery to remove colon cancer Exclusion Criteria: * pregnancy * colon cancer with invasion to perineum * palliative surgery * history of diagnosis or surgery for other cancer * emergent surgery * ASA PS classification 4 and 5 * refusion to participate in the study * allergy to anesthetics

Primary outcome measure(s)

Trial sites (2)

FacilityCityRegionStatus
Seoul Metropolitan Government Seoul National University Boramae Medical Center Seoul South Korea
Seoul National University Hospital Seoul South Korea

More Seoul National University Hospital trials in South Korea

Reduction of Remifentanil-related Complications Starting soon
Implementation of the ERAS in Colorectal Cancer Patients: a Single Arm Study Enrolling by invitation
Individualized Versus Conventional Perioperative Blood Pressure Management Recruiting
PersonaLized neoAdjuvant Strategy ER Positive and HER2 Negative Breast Cancer TO Increase BCS Rate Active, not recruiting
Intrathecal Morphine Injection Versus Continuous Wound Infiltration After Pancreaticoduodenectomy Recruiting

Other trials for the same condition

Reduction of Remifentanil-related Complications Starting soon
Anesthesia and Non-small Cell Lung Cancer Recurrence Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT04259398 on ClinicalTrials.gov ↗ ← All trials in South Korea